Quest Diagnostics Incorporated (BIT:1QDX)

Market Cap	17.09B
Revenue (ttm)	8.96B
Net Income (ttm)	804.67M
Shares Out	n/a
EPS (ttm)	7.11
PE Ratio	21.24
Forward PE	17.48
Dividend	2.98 (2.05%)
Ex-Dividend Date	Jul 4, 2025

Volume	n/a
Average Volume	16
Open	145.50
Previous Close	145.50
Day's Range	145.50 - 145.50
52-Week Range	145.15 - 159.55
Beta	n/a
RSI	34.20
Earnings Date	Jul 22, 2025

About Quest Diagnostics

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans,...

• Industry: Medical Laboratories
• Founded: 1967
• Employees: 56,000
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1QDX

Financial Performance

In 2024, Quest Diagnostics's revenue was $9.87 billion, an increase of 6.70% compared to the previous year's $9.25 billion. Earnings were $866.00 million, an increase of 1.88%.

Financial numbers in USD